Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Nasopharyngeal Carcinoma 6 Uterine Cervical Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Esophageal Squamous Cell Carcinoma 4 Pancreatic Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Stomach Neoplasms 2 Nasopharyngeal Neoplasms 2 Uterine Cervical Dysplasia 1 Solid Tumors 1 Solid Tumor 1 Recurrence 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Nasopharyngeal Diseases 1 NSCLC 1 Meningeal Carcinomatosis 1 Lung Neoplasms 1 Locally Advanced Rectal Cancer 1 Hypopharyngeal Neoplasms 1 Head and Neck Neoplasms 1 HCC 1 Esophageal Neoplasms 1 Diffuse Intrinsic Pontine Glioma 1 Childhood Brain Stem Neoplasm 1 Carcinoma, Squamous Cell 1 Breast Neoplasms 1 Advanced Pancreatic Cancer 1 Advanced Colorectal Cancer 1 Advanced Cancer 1

Interventions

Temozolomide 2 nimotuzumab 1 Vinorelbine 1 Valproic Acid 1 Radiotherapy 1 Everolimus 1 Erlotinib Hydrochloride 1 Drug Therapy 1 Dasatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Diffuse Intrinsic Pontine Glioma × nimotuzumab × Clear all

NCT03620032 2023-12-06

DIPG

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Unknown

Diffuse Intrinsic Pontine Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡